Search results
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to...
Valley City Times Record· 2 days ago- Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
Zacks via Yahoo Finance· 1 day agoPer the agreement, AbbVie will make an upfront payment of $65 million to Gilgamesh. The...also...
AbbVie shares hold Buy rating with $180 target from TD Cowen By Investing.com
Investing.com· 1 day agoOn Tuesday, TD (TSX:TD) Cowen maintained a positive stance on AbbVie Inc . TD Cowen adjusted its...
What Is the Dividend Payout for AbbVie Stock?
Motley Fool via Yahoo Finance· 2 days agoIndustry-based diversification, however, isn't all the pharmaceutical outfit brings to the table. AbbVie is also a quality dividend stock. If you're...
... Post-Rescheduling? Data Analytics Expert Weighs In - Corbus Pharmaceuticals (NASDAQ:CRBP), ...
Benzinga· 1 day agoKey states driving this surge include New York, New Jersey and potentially Florida and Ohio, Bingham...
Earnings call: Ironwood Pharmaceuticals reports robust Q1 growth By Investing.com
Investing.com· 5 days agoIronwood Pharmaceuticals, Inc. (NASDAQ: IRWD) provided an update on its financial and operational...
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Motley Fool via Yahoo Finance· 5 days agoIt sells a rival product to Ozempic in Mounjaro, giving Eli Lilly similar upside exposure....
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 6 days agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further...
Digital Journal· 10 hours agoThis biologic serum has...Lance Alstodt, BioRestorative's CEO. BioRestorative is not the only pharmaceutical company interested in the medical aesthetics market; companies ...
2nd Circuit Clarifies When ‘Pay-for-Delay’ Deals Are Legal in Tossing Antitrust Claims | Law.com
Law.com· 1 day agoThe U.S. Court of Appeals for the Second Circuit on Monday upheld the dismissal of a lawsuit...
